Biofrontera
BFRIW
5 hedge funds and large institutions have $81.8K invested in Biofrontera in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
75% more capital invested
Capital invested by funds: $46.7K → $81.8K (+$35.1K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.26% more ownership
Funds ownership: 0.99% → 1.25% (+0.26%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$26.9K |
| 2 |
US Bancorp
Minneapolis,
Minnesota
|
+$250 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.91K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2 |
BFRIW Hedge Fund Activity: Q1 2023 in Review
5 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q1 2023, worth a combined $81.8K — up 75% from $46.7K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BFRIW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $26.9K. The largest seller was Susquehanna International Group, cutting an estimated $1.91K.
- 5 institutional investors held Biofrontera (BFRIW) as of Q1 2023, up from 4 in Q4 2022.
- Funds reported $81.8K of Biofrontera stock for Q1 2023, up 75% quarter-over-quarter.
- 2 funds opened new Biofrontera positions in Q1 2023 and 1 closed out, a net change of +1 holder.
- The largest Biofrontera buyer in Q1 2023 was Osaic Holdings, an estimated $26.9K added.
- The largest Biofrontera seller in Q1 2023 was Susquehanna International Group, an estimated $1.91K sold.
Based on aggregated 13F filings for Q1 2023.